As shown in the results, the expression levels of immune checkpoints were differential in different groups, especially PD-1, CTLA4 and LAG3, which are commonly found in renal cancer, were more significantly expressed in the high-risk group. This evidence concerns the gene CTLA4 and renal carcinoma.